Glenmark Pharmaceuticals said on Monday it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections.

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated December 09, 2013, titled "Glenmark announces launch of Hydrocortisone Butyrate cream in the US". Glenmark Generic INC ...

Glenmark Pharmaceuticals has entered into a agreement with Triax and Astellas to resolve a patent infringement case in the US over its generic hydrocortisone butyrate cream, used for the treatment ...

Glenmark believes that it is entitled to 180 days of exclusivity with respect to its hydrocortisone butyrate cream, as it is the first generic company to file an ANDA for the product. Triax ...

As per the royalty-bearing licence agreement, Glenmark is entitled to 180 days of exclusivity for its Hydrocortisone Butyrate Cream, as it is the first generic company to file an Abbreviated New ...

TELIGENT INC- ‍EXPECT TO LAUNCH HYDROCORTISONE BUTYRATE LOTION 0.1% IN Q1 OF 2018 Source text for Eikon: Further company coverage: Sign up here. Healthcare & Pharmaceuticalscategory Bain ...